Check our economic calendar for dates, times, estimates, actual results, and trading importance for major U.S. economic releases. See economic data for yesterday, today, tomorrow, and weekly up to six ...
Check our economic calendar for dates, times, estimates, actual results, and trading importance for major U.S. economic releases. See economic data for yesterday, today, tomorrow, and weekly up to six ...
* Ex-Date is the date that the stock price is scheduled to adjust on the respective exchange. Cookies are essential for making our site work. By using our site, you consent to the use of these cookies ...
* Ex-Date is the date that the stock price is scheduled to adjust on the respective exchange. Cookies are essential for making our site work. By using our site, you consent to the use of these cookies ...
Coupang (CPNG -11%) sinks today despite surpassing earnings and sales estimates in Q3 on a decent uptick in active customers and improving profitability within its new business division. Shares of the ...
CVS Health (CVS +10%) delivers Q3 earnings in-line with its previously lowered forecast and topples revenue expectations in the quarter, sufficient to alleviate recent selling pressure today. Shares ...
Chemical company DuPont (DD) may not be the first name that comes to mind when thinking about AI plays, but the emergence of new AI technologies was a key factor behind the company's ...
Get the inside scoop before everyone else with our superior stock market analysis and stock picks to profit in today's markets.
[BRIEFING.COM] S&P futures vs fair value: +10.00. Nasdaq futures vs fair value: +65.00. The S&P 500 futures are up ten points and are trading 0.2% above fair value, the Nasdaq 100 futures are up 65 ...
Election Day is here, and it must feel like the Fourth of July, Halloween, and Christmas Day wrapped into one for political pundits. There will be fireworks, there will be treats (hopefully, no tricks ...
For back-to-back quarters, Palantir Technologies (PLTR +21%) delivered beats on its top and bottom lines in Q3 and forecasted upbeat Q4 revenue figures. Not much has been able to slow PLTR down this ...